Advertisement
Patterns of brain atrophy differ between active and retired boxers
In one of the largest studies to follow MRI brain volumetrics among professional athletes exposed to repetitive head injury (RHI), active boxers were found to have progressive atrophy in regions that differed from those in their older, retired counterparts. In addition, fighters with significant caudate volume loss had measurable cognitive impairment.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The findings, from Cleveland Clinic’s longitudinal Professional Fighters Brain Health Study, were published in Neurology (2020;94:e232-e240).
“The differences in regional brain volumes may reflect distinct pathologic processes that occur at different stages of head injury,” says lead investigator Charles Bernick, MD, MPH, a staff physician with Cleveland Clinic’s Lou Ruvo Center for Brain Health in Las Vegas. “Identifying biomarkers of changing brain structure or function could contribute to understanding these processes and may one day prove to be a useful tool for research and clinical purposes.”
In recent years, interest in the neurological effects of repeated head trauma in athletes has abounded, but a clear understanding of underlying pathologic mechanisms has been lacking. The study sought to characterize MRI volumetric changes in people with RHI with the aim of identifying biomarkers potentially applicable to determining prognosis, developing risk-reduction strategies and defining cohorts and outcome measures for clinical trials.
Data were drawn from Cleveland Clinic’s Professional Fighters Brain Health Study, an ongoing longitudinal study of licensed mixed martial arts (MMA) fighters and boxers. Participants undergo annual MRI scanning and cognitive testing, as well as blood testing for neurofilament light (NfL) and tau levels.
The study group consisted of 204 participants from the following cohorts:
Advertisement
Each participant had completed at least two annual assessments; follow-up averaged 2.6 years, with the longest time between baseline and the last visit being six years.
Key findings included the following:
Overall, no significant differences were found in cognitive testing between controls and active or retired fighters. However, among active fighters, processing speed (Trail-Making Test parts A and B) was poorer in those who had a more than 1.5% average yearly decline in caudate volumes compared with those who did not.
“The significance of the different patterns of volumetric decline found in this study has yet to be determined,” Dr. Bernick points out. “However, the findings are intriguing and deserve further scrutiny.”
Advertisement
He explains that the study’s relatively short follow-up to date may be responsible for the paucity of association between volumetric declines and clinical measures, and that new and stronger links may reveal themselves as this longitudinal database grows and ages.
An accompanying editorial by two vascular neurologists from Harvard Medical School and Massachusetts General Hospital states that the study “represents an important advance in the study of athletes subjected to RHI.” The editorialists note: “[F]uture studies building on these results may identify clinically meaningful predictors of irreversible injury and long-term sequelae…permitting risk reduction before patients reach a point of no return.”
Advertisement
Advertisement
Understanding TE involvement is a key to developing new treatments
Study aims to inform an enhanced approach to exercise as medicine
$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
Chronic stress, asymptomatic disease affect different brains differently
Real-world claims data and tissue culture studies set the stage for randomized clinical testing
New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study
How the new longitudinal investigation could become the Framingham Heart Study of brain health